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Giant Magnetoresistive 
Biosensors for Time-Domain 
Magnetorelaxometry: A Theoretical 
Investigation and Progress Toward 
an Immunoassay
Chih-Cheng Huang1,*, Xiahan Zhou2,* & Drew A. Hall2
Magnetorelaxometry (MRX) is a promising new biosensing technique for point-of-care diagnostics. 
Historically, magnetic sensors have been primarily used to monitor the stray field of magnetic 
nanoparticles bound to analytes of interest for immunoassays and flow cytometers. In MRX, the 
magnetic nanoparticles (MNPs) are first magnetized and then the temporal response is monitored 
after removing the magnetic field. This new sensing modality is insensitive to the magnetic field 
homogeneity making it more amenable to low-power portable applications. In this work, we 
systematically investigated time-domain MRX by measuring the signal dependence on the applied 
field, magnetization time, and magnetic core size. The extracted characteristic times varied for different 
magnetic MNPs, exhibiting unique magnetic signatures. We also measured the signal contribution 
based on the MNP location and correlated the coverage with measured signal amplitude. Lastly, we 
demonstrated, for the first time, a GMR-based time-domain MRX bioassay. This approach validates the 
feasibility of immunoassays using GMR-based MRX and provides an alternative platform for point-of-
care diagnostics.
Dramatic improvements in medicine and the healthcare system over the past century have increased the average 
life expectancy worldwide as a result of better understanding of disease processes, new treatments, and advances 
in pharmaceuticals1. Yet, the largest contributor to this advancement is the earlier diagnoses of life threatening 
diseases, where treatments are much more effective and physicians have more options. Historically such medical 
decision making was primarily symptom driven whereas today it is increasingly reliant on molecular tests that 
analyze patient samples for disease-specific biomarkers (e.g., proteins, DNA, etc.). Current clinical biomarker 
detection technologies, such as colorimetric and fluorescent enzyme-linked-immunosorbent assays (ELISA), 
have proven to be effective, yet are confined to centralized laboratories, have time consuming and labor intensive 
protocols, and require expensive equipment2,3. These limitations have fueled research into alternative biosensing 
technologies that require less sample preparation and are more portable.
For the past two decades, magnetic biosensors have received considerable attention as they offer several key 
advantages over conventional and competing sensing methods4–18. Like an ELISA, a magnetic immunoassay 
(MIA) relies on two antibodies that form a sandwich structure around the biomarker of interest to achieve high 
specificity. However, the optical label in an ELISA is replaced with a 10–50 nm magnetic nanoparticle (MNP) in 
the MIA. This switch of label has been shown to retain sensitivity in unprocessed samples due to the lack of mag-
netic background signal5, reduce the need for tedious sample preparation19, allow for sample manipulation with 
magnetic fields20,21, and enable real-time monitoring of the binding kinetics4. However, the minute signal from 
the MNPs requires specialized magnetic sensors to be detected.
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Early work developing magnetic biosensors can be traced back to 1990’s, and, since then, researchers have 
demonstrated biosensing using a host of different magnetic sensors including superconducting quantum interfer-
ence devices (SQUIDs)22, inductive sensors23, hall effect sensors20,21, flux-gate magnetometers24, and magnetore-
sistive (MR)-based sensors15,25–27. Among the many magnetic sensors available today, MR-based devices standout 
for point-of-care (POC) applications. In addition to the inherent advantages of magnetic biosensing, MR biosen-
sors can be operated at room temperature, have high low-field sensitivity, and have comparably high transduction 
efficiency. These MR-based sensors operate on a quantum mechanical effect (either spin-dependent scattering or 
tunneling) where the resistance is proportional to the magnetic field with magnetoresistance ratios ranging from 
5% to > 200% for modern devices8,28.
Previously, these MR biosensors utilized static magnetometry where one detects the MNP’s stray field in 
response to a DC or fixed frequency AC magnetic field. However, this technique requires a homogeneous mag-
netic field, complex readout electronics, and substantial signal processing to extract the minute signal of interest, 
all of which are challenging to do in a power constrained, remote POC environment. An alternative approach is 
based on magnetorelaxometry (MRX) where one detects the relaxation signature in response to a pulsed mag-
netic field. This technique removes the need for a homogenous magnetic field and requires comparably simpler 
readout electronics and signal processing. Figure 1 illustrates how this technique is applied for magnetic biosens-
ing. In the absence of an external magnetic field, the magnetic moments of the superparamagnetic MNPs teth-
ered to the surface of the sensor are randomly oriented resulting in zero net field (Fig. 1a). Then, a magnetic field 
(HA) is applied that magnetizes and aligns all the MNPs. The stray field from the MNP opposes the applied field 
resulting in a small change in resistance in the underlying MR sensor (Fig. 1b). Note, this is the region of opera-
tion for static magnetometry. However, in MRX, the applied magnetic field is then switched off and the sensors 
are monitored as the MNPs gradually relax to their equilibrium state (Fig. 1c). This relaxation occurs due to Néel 
and Brownian relaxation. Néel relaxation is the result of internal magnetic domain movement within the MNP 
whereas Brownian relaxation is the rigid rotation of the entire MNP. Since the MNPs are tethered to the surface of 
the sensor via antibodies or other molecular recognition elements, the relaxation process is predominantly Néel 
based. This relaxation signal can be measured in either the frequency- or time-domain. The frequency-domain 
technique uses a continuous AC magnetic field to measure the in-phase and out-of-phase component of the 
susceptibility whereas the time-domain technique measures the temporal response due to a pulsed magnetic 
field. In a POC setting, the time-domain technique generally leads to a simpler implementation, but requires 
careful understanding of the factors that influence the signal, which, in the past, has limited the progress  of this 
technique.
In this paper, we propose a novel time-domain MRX-based giant magnetoresistance (GMR) biosensor to 
observe Néel relaxation of tethered MNPs. To investigate this, we designed an ultrafast electromagnet with a 
switching time less than 5 μ s (slew rate > 1,000 T/s), which is much faster than the state-of-the-art with a 400 μs. 
switching time (slew rate of 37 T/s)29, to minimize the deadzone. Low-noise readout electronics were designed 
to capture the relaxation signal. The effect of the applied magnetic field amplitude (HA) and magnetization time 
(tmag) were explored to understand their influence on the relaxation process. The results show excellent agreement 
with the empirical trend describing the relaxation based on natural-log behavior. We use these findings to opti-
mize the system and perform a proof-of-principle magnetic immunoassay, which is, to the best of our knowledge, 
the first time that GMR sensors have been reported for an MRX bioassay.
Figure 1. Illustration of time-domain magnetorelaxometry. (a) Magnetization phase (field HA > 0 Oe) where 
the MNP magnetic moments are aligned to the applied field. (b) Relaxation phase (field HA = 0 Oe) where the 
MNP magnetic moments gradually randomize. (c) The corresponding resistance of an MR sensor in response to 
the external magnetic field with and without MNPs.
www.nature.com/scientificreports/
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Results
The measurement setup consisted of an 8 × 10 GMR sensor array (MagArray Technologies, Inc.) placed inside an 
electromagnet (custom designed) connected to readout circuitry (custom designed) as shown in Fig. 2 (described 
in detail in the Methods section). Due to the correlated double sampling technique (described in the Methods 
section), no magnetic shielding was required. Each sensor contained multiple GMR stripes to increase the surface 
area while maintaining the high aspect ratio of each stripe needed to keep the sensing layer stable with a nomi-
nal resistance of 1.7 kΩ and a magnetoresistance ratio of 11.5% (Fig. 2c). Streptavidin-coated MNPs (SHS-30-01, 
Ocean NanoTechnologies) were drop-casted on the sensors in the presence of an alternating field (50 Oe at 200 Hz) 
and allowed to dry before the experimental investigation of characteristic time, coverage, and signal dependence 
(over applied field and magnetization time). Prior to drop-casting, select sensors were covered with epoxy to pre-
vent the MNPs from being in close enough proximity to the sensor (~200 nm) to create a detectable signal. These 
epoxy-coated sensors were used as negative controls (reference sensors) while all others were active sensors with 
MNPs. For magnetic immunoassay experiments, the reference sensors were coated with Bovine serum albumin 
(BSA) while active sensors were functionalized with biotin, which facilitated binding with the MNPs through the 
high affinity streptavidin-biotin interaction. With the above setup and experimental procedures, we successfully 
monitored the relaxation process of MNPs. The active sensors exhibited a natural log-like response with a char-
acteristic time of 3.3tmag while the reference sensors showed no response. Next, we extended the investigation to 
extract the MNP coverage and confirmed it with scanning electron microscope (SEM) analysis. The measured 
signal was found to be proportional to the MNP concentration. To improve the empirical and theoretical study 
of time-domain MRX, we investigated the signal dependence on the applied field, magnetization time, and MNP 
size/composition. The results showed that other contributors (i.e. temperature and MNP dispersity) need to be 
considered as well. The measurements of different MNPs showed that each has a unique tc roughly proportional 
to the core volume. Lastly, we performed a magnetic immunoassay to demonstrate the feasibility of this approach.
Investigation of Characteristic Time. Once the MNP is magnetized and the field is removed, there is 
insufficient energy to keep the moment of the MNP fixed. There are two mechanisms by which this loss of energy, 
or relaxation process, can occur. With two competing processes, the relaxation time will depend on the faster of 
the two mechanisms. Néel relaxation follows an exponential decay relationship when the MNPs are monodis-
perse30–33, and depends on the core volume and anisotropy of the MNP as described in Equation (1)
τ τ=






KV
k T
exp ,
(1)
N
B
0
where τ0 is the attempt time (usually approximated as 10−9 sec), K is the anisotropy constant of the MNP, V is the 
core volume of the MNP, kB is Boltzmann’s constant, and T is the absolute temperature. However, this relation-
ship becomes natural log-like when considering particle-particle interactions and the size/shape distributions of 
the MNPs30–36. The time course magnetization during relaxation can be empirically described by the following 
equation
κ= 

 +


M t aM
t
t
( ) ln 1 ,
(2)N
c
0
where MN is the magnetization, κ is the surface coverage, a is a constant related to the magnetic viscosity, M0 
is the initial MNP magnetization before the applied magnetic field is removed, t is the time after turning off 
the field, and tc is the characteristic time that has a strong dependence on the applied magnetic field (HA) and 
magnetization time (tmag). It has been previously reported that tc ≈ tmag when the applied field is relatively small 
(HA = 0.1 Oe)31. However, this has not been measured for more moderate magnetic fields that are appropriate for 
MR-based biosensing (20–100 Oe).
To measure the relaxation response, we restricted the particles to Néel relaxation by drop-casting a fixed vol-
ume of MNPs on the surface of the MR sensors and allowing them to dry while applying a magnetic field (50 Oe 
Figure 2. (a) Simplified measurement setup with electromagnet and sensor array. (b) Photograph of GMR 
sensor array. (c) Optical microscope image of a GMR sensor and measured magnetoresistance curve.
www.nature.com/scientificreports/
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at 200 Hz). In such a configuration, the particles are rigidly attached and cannot undergo Brownian relaxation, 
thereby serving as a model system for the MIA. Moreover, the MNPs preferentially migrate into the trenches (the 
area between the stripes of GMR) in the presence of external field during the drying process, which significantly 
enhances the sensor response when MNPs are located close to the edge of trenches37,38. In these experiments, we 
followed the time-domain MRX procedure previously described (Fig. 1). The applied magnetic field (HA) was set 
to 50 Oe and pulsed for a duration of 100 ms. The field was subsequently collapsed in under 10 μ s. The resulting 
resistances of the MR sensors were measured by applying a constant voltage across the sensors and integrating the 
current (described in the Methods section). The integrators were synchronized to start integrating after the elec-
tromagnet was turned off. The sensor array contained both active sensors (n = 29) and reference sensors (n = 20), 
which were coated with a thick epoxy to prevent the MNPs from being near the MR sensor thus quenching the 
relaxation signal.
The reference sensors all showed near zero signal, as expected, whereas the active sensors all exhibited a char-
acteristic MRX signal with an amplitude ranging from 2 mV to 15 mV (Fig. 3a) due to the uncontrolled coverage 
on each sensor. When normalized by scaling the amplitudes to be the same (Fig. 3b), it is readily apparent that 
each sensor is measuring the same process, just scaled by the surface coverage. From the fitted data, we found 
that tc = 3.3tmag = 330 ms for HA = 50 Oe and tmag = 100 ms (Fig. 3c). Using magnetic modeling (described in the 
Methods section) to simulate the response of this system with the same tc, we found that the simulation results are 
in good agreement with the measured data. As will be shown later, tc can be used as a unique magnetic signature 
for each type of MNP.
Coverage Extraction. After verifying the natural log behavior of the relaxation signal and measuring the 
corresponding characteristic time, we investigated the signal dependence on the MNP coverage. For the detection 
of biomolecules labeled by MNPs, extraction of the MNP coverage is required to quantitatively retrieve the con-
centration of analytes and further deduce the ligand-receptor interaction characteristics, such as binding affinity 
and kinetics. In this section, we conducted the proof-of-principle experiments, extracting the coverage of MNPs 
in the absence of probe molecules (i.e., surface immobilization). For a single MNP, the signal would be highly 
dependent on the location within the sensor38. However, with moderate surface coverage, the signal per MNP is 
roughly constant and independent of location other than if it is on top of the sensor or in the trench next to the 
sensor39,40. Previously we were only able to calculate the relative MNP coverage based on the signal amplitude. To 
precisely extract the coverage parameter κ in Equation (2), we applied different MNP concentrations and imaged 
the sensors using a SEM after MRX measurements (Fig. 4). The number of MNPs on the sensor was calculated 
from the SEM images and compared with the corresponding measured MRX curve. The signal is dependent on the 
concentration of MNPs as shown in Fig. 4a, and the average signal at t = 150 ms is 0.86 mV, 5.34 mV, and 10.51 mV 
for 0.02× , 0.1× , and 2× the concentration of SHS-30 MNPs, respectively. It is important to note that the ratio of 
average signals between 0.02× and 0.1× the concentration (Signal0.02×/Signal0.1× = 0.16) is similar to the ratio of 
their concentrations (Conc0.02×/Conc0.1× = 0.2); however, this linear concentration dependence did not adequately 
represent the signal with higher MNP concentration (2× ), since multi-layer MNP structures were formed at this 
high of concentration. Furthermore, high MNP concentration is not a realistic scenario for bioassays where a 
monolayer is the theoretical limit due to the surface ligand binding. Consequently, we focused on the 0.02× and 
0.1× MNP concentrations to extract the coverage where the signal per particle is linear and the coverage is still 
monolayer (Fig. 4b). Since the design of the sensor geometry results in different signals that depend on the MNP 
position (i.e., on the stripe vs. trench)37, the total coverage over sensor area is not sufficient to address and extract 
the information of MNP coverage. Instead, the coverage should be evaluated over the GMR stripes and trenches 
(area between adjacent stripes), respectively. Equation (2) is modified accordingly to account for this dependency
Figure 3. (a) Measured MRX signals from active sensors (blue, n = 29) and reference sensors (red, n = 20). The 
different amplitudes indicate non-uniform MNP coverage. (b) Normalized relaxation signals demonstrating 
the homogeneous relaxation behavior. The curves are the mean signal of reference sensors and active sensors, 
respectively. Error bars are ± 1σ . (c) Comparison between experimental data and simulation exhibits good 
consistency of the characteristic time of 3.3tmag. Error bars are ± 1σ .
www.nature.com/scientificreports/
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where Cs and Ct are dimensionless coefficients containing the magnetic viscosity and signal per particle on the 
sensor and trench, respectively, and ks and kt are the stripe and trench coverage in terms of percentage. From 
the measured data, we found that Cs = − 0.039 ± 0.02 and Ct = 0.11 ± 0.018 (Fig. 4c). The inequality of Cs and 
Ct proves the positional dependence and reaffirms the previously reported result that the MNPs in the trenches 
contributed to signal more than the MNPs on the stripes38. The correlation between signal and extracted coverage 
coefficients exhibited strong consistency (R2 = 0.90) as shown in Fig. 4c.
Signal Dependence on External Field and Magnetization Time. Subsequently, we extended the 
experiment to measure the signal dependence on HA and tmag to optimize the time-domain MRX response. As 
expected, tc has strong dependence on HA and tmag (Fig. 5a), varying from 85 ms to 450 ms in the given range of 
HA and tmag. Based on our results, tc has a quasi-linear relationship with tmag, while being exponentially depend-
ent on HA (Fig. 5b,c). The underlying theory still needs to be investigated to validate this observation. It should 
be noted that the extracted tc = 380 ms at HA = 50 Oe and tmag = 100 ms is not the same as previously measured 
(tc = 330 ms). We believe that this discrepancy is a result of different measurement temperatures (particularly 
here where the electromagnet was running for an extended duration resulting in an elevated temperature). 
Nevertheless, the signal amplitude followed the trend of tc, as expected, when sweeping HA and tmag (Fig. 5a). The 
normalized data, which were processed to remove the coverage effect, showed a positive correlation with HA and 
tmag (Fig. 5b,c). In terms of signal amplitude (Fig. 5d–f), the normalized signals show diminishing returns when 
increasing HA and tmag, i.e. the increasing trend of the signal is not as obvious as tc with increasing HA and tmag.
Characteristics of Time-domain MRX. Based on the previous sections, we can enhance the signal 
through increasing the external field, magnetization time, and MNP concentration. In this experiment, we fixed 
HA = 75 Oe and tmag = 150 ms and investigated the signal from different MNPs. According to the literature and 
datasheets41–43, the mean cores size are 7.7 nm, 12 nm, and 30 nm for MyOne, Nanomag-D, and SHS-30, respec-
tively. The normalized signals, which eliminate the effect of coverage, exhibited characteristic signatures unique 
to each MNP (Fig. 6a), and the extracted characteristic times of these three MNPs varied from 270 ms to 480 ms 
(Fig. 6b). The measurements were conducted under the same ambient temperature, hence the differences in the 
normalized signal must be from the different characteristic times. These results agree with the increased Néel 
Figure 4. (a) Average signal under different MNP concentrations. (b) Measured relaxation signals and the 
corresponding SEM images. The three representative sensors, varied from low to high coverage of MNPs, 
exhibited high signal dependence over coverage. (c) Extraction of surface coverage showed different signal 
responses between stripe coverage and trench coverage. The fitted coefficients Cs and Ct are − 0.039 and 0.11, 
respectively.
www.nature.com/scientificreports/
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relaxation time as described in Equation (1) where the time is dependent on the core volume. While time-domain 
MRX was substantially limited by the deadzone time (switching time) of the magnetic field in earlier work31,33, 
we have dramatically improved the time-domain MRX system with GMR sensors and successfully detected three 
kinds of MNPs.
Progress Toward Magnetic Immunoassay. To demonstrate MRX as a biosensing technique, we performed 
an immunoassay and compared the results to the conventional magnetometry approach. In this experiment, the 
active sensors were functionalized with biotin whereas reference sensors were functionalized with BSA. The pro-
tocol used to functionalize the sensors is described in the Methods section. It should be noted that this protocol 
Figure 5. Measurement results showing: the effect of (a) HA and tmag on tc, (b) tc on HA, (c) tc on tmag, and (d) 
HA and tmag on the (normalized) signal  amplitude as well as the relaxation signal under (e) HA = 50 Oe with 
increasing tmag and (f) under tmag = 100 ms with increasing HA.
Figure 6. (a) Measured relaxation curves for different MNP and (b) the extracted characteristic time annotated 
with the core size of the MNP. Measurements repeated on multiple sensors (n = 62, 45, 49, respectively.) Error 
bars are ± 1σ .
www.nature.com/scientificreports/
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was designed specifically for the SHS-30 MNPs that have a zeta potential between − 40 mV to − 20 mV44,45. To 
compare both techniques, MRX measurements were taken before and after adding the streptavidin-coated MNPs 
to the assay. The assay was monitored in real-time using conventional magnetometry6 (Fig. 7a). As expected, the 
streptavidin-conjugated MNPs bound to the biotin on the surface of the active sensors. The reference sensors showed 
no signal, indicating no specific binding. The corresponding coverage maps are shown in Fig. 7b,c for magnetometry 
and magnetorelaxometry, respectively. Both coverage maps show a high degree of similarity, confirming the validity 
of the proposed technique. Since the noise is uncorrelated in the MRX measurements, repeated measurements can 
improve the signal to noise ratio at the expense of an increased measurement time. This proof-of-principle experi-
ment demonstrates the potential of utilizing the proposed time-domain MRX for in-vitro diagnostics.
Discussion
Unlike the traditional magnetometry which only measures the magnetic field, spin relaxometry (i.e., electron spin 
and nuclear spin) measures the temporal magnetic response arising from the unique atomic structure. Early 
development on magnetic relaxation for biomedical applications focused on nuclear magnetic resonance (NMR) 
based on nuclear spin relaxation46,47. With the endeavor of miniaturization of NMR devices48–51, 
relaxometry-based microchips have drawn attention recently and are moving toward molecular/cellular diagnos-
tics using electron spin relaxation (ESR). However, both NMR and ESR typically require large magnets to gener-
ate the polarizing field limiting their miniaturization. With the state-of-the-art semiconductor technologies, 
MR-based biochips have the merits of low cost, as well as improved compatibility with lab-on-a-chip systems, 
integrated electromagnets, and complementary metal-oxide-semiconductor (CMOS) that can be further applied 
in POC settings using MRX. Although MRX has been investigated for two decades, the lack of systematic study 
of MNP characteristics for temporal measurement has prevented time-domain MRX from being a reliable bio-
sensing technique. Previously, the deadzone time restrained time-domain MRX from surface immunoassays, 
urging MRX toward frequency-domain measurements with homogeneous assays. While frequency-domain 
MRX has shown promise for homogeneous assays18,52, its high dependence on hydrodynamic volume decreases 
the distinguishability between analytes. Also, homogeneous assays increase the distance between analytes and 
sensor surface that would remarkably diminish the magnetic signal ∝ d( 1/ )3 . Due to the above challenges in MRX, 
there is an urgent need to re-innovate time-domain MRX in unprocessed samples without the loss of magnetic 
sensitivity. Some state-of-the-art works substantially improved the temporal limit of MRX by using Hall-effect 
sensors and inductive microchips with a high sampling-rate analog to digital converter to capture the dynamic 
response20,21,53–55. Yet, the realization on bioassay using time-domain GMR MRX hasn’t been reported to date.
In this work, we successfully demonstrated a time-domain MRX for biotin-streptavidin assay using GMR bio-
sensors to investigate the temporal relaxation of commercial MNPs. The experimental investigation was designed 
on a theoretical basis with the investigation of Néel relaxation of dry MNPs which is prohibited from Brownian 
relaxation, coverage correlation that demonstrated unequal contribution of signal from stripes and trenches, 
extraction of characteristic time of different MNPs that proved the feasibility of distinguishing various MNPs in 
an assay, and the first realization using GMR on time-domain bio-MRX. In summary, the systematic investigation 
of our work on time-domain MRX enables us to perform bio-MRX with GMR biosensors.
Methods
GMR Sensor Chip and Magnetic Nanoparticles. GMR sensor chips were purchased from MagArray. Each 
GMR chip has 80 individually addressable sensors arranged in 8 × 10 matrix with a nominal resistance (R0) of 1729 Ω 
and a magnetoresistance ratio of 11.5%. The sensors do have hysteresis and anisotropy; however, this does not affect 
the proposed MRX measurement technique since the field is always swept along the same path and the resistance 
differential is measured. The magnetic particles used in all experiments were coated with streptavidin and purchased 
Figure 7. (a) Measured real-time magnetic immunoassay based on magnetometry, the curves are the mean 
signals of reference sensors (red, n = 8) and active sensors (blue, n = 25), respectively. Error bars represent ± 1σ. 
Corresponding coverage map for (b) magnetometry and (c) magnetorelaxometry.
www.nature.com/scientificreports/
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from Ocean NanoTech (catalog #: SHS-30-01), Micromod Partikeltechnologie GmbH (Nanomag® -D 130 nm, cata-
log #: 09-19-132), and Thermofisher Scientific (Dynabeads® MyOne™ Streptavidin T1, catalog #: 65601).
Magnetic Simulation, Modelling, and Fitting. To calculate the MNPs’ average field on a GMR sensor, we 
adopted Stoner–Wohlfarth (SW) model for magnetic modelling. Assuming MNPs are Langevin spheres in the field 
regime (2–100 Oe), MNPs have a linear superparamagnetic response and give rise to a dipole field. The volume 
susceptibilities of SHS-30, Nanomag-D 130 nm, and MyOne at room temperature are 3.60, 4.44, and 1.38 (SI unit, 
dimensionless), respectively41–43. Here, we consider only the spatially averaged magnetic field Hs on the sensor from 
MNPs being magnetized by the applied field HA. Thus, the average field of a single MNP in the free layer Hb  is:
∫ ∫ ∫
χ
= ⋅
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where l is the sensor length, w is the sensor width, and t is the free layer thickness χ is the dimensionless magnetic 
susceptibility, RB is the MNP radius, HA is the applied magnetic field, r is the distance between MNP and the 
center point of free layer, x and y are the in-plane axes, and z is the out-of-plane axis. Consequently, we neglect the 
component along long-axis (x, as Fig. 1) of the sensor due to insensitivity of the long-axis field, and only consider 
the average field along the short-axis (y)
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To extract the characteristic time (tc), a MATLAB script was written that incorporates these equations, critical 
volume approximation30, and the signal transduction to calculate the corresponding resistance change as
∆ = 

 +


 HR t S
t
t
( ) ln 1 ,
(6)s y
c
0
where S0 is the sensor sensitivity (Ω/Oe), t is the time after turning off the field, and tc is the characteristic time.
Measurement Setup. The measurement setup consisted of a computer running MATLAB, a field pro-
grammable gate array (FPGA, Opal Kelly XEM6310) to control the timing, a power amplifier (PA, Kepco BOP 
36–12 ML), a custom designed coil driver and Helmholtz electromagnet, and custom designed readout electron-
ics (Fig. 8). The computer can digitally adjust both the magnetic field and magnetization time through the FPGA. 
The current from the sensors was integrated and then digitized using a National Instruments data acquisition card 
(NI PCIe-6351). To remove DC offset, temperature drift, 1/f and other correlated noises, and circuit non-linearity, 
a correlated double sampling (CDS) technique is used where the sensor is sampled two different times: once 
with the magnetic field and once without the magnetic field. The CDS technique eliminates the need for mag-
netic shielding, which is extensively used to minimize magnetic noise, circuit non-linearity, and hysteresis29. The 
extracted signal (Δ Vout) can be written as:
∫∆ = − ≅ ⋅ ∆V V V
V
R C
R t dt( ) ,
(7)
B
F
out out field out no field
0
2
where VB is the bias voltage (0.5 V), CF is the integration capacitor, and Δ R is the magnetoresistance signal 
due to the MNP. Multiple measurements were averaged to reduce the white noise and further improve the 
signal-to-noise ratio (SNR).
Figure 8. Simplified schematic of measurement system. 
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MNP Handling and Coverage Analysis. MNPs were washed with DI water before using, the resulting 
elimination of salt concentration improved the accuracy of coverage analysis. The MNP coverages were analyzed 
by MRX signals and SEM images, respectively. A FFT bandpass filter was applied during image processing to 
increase the contrast between MNPs and sensor substrate through software ImageJ. The MNP concentration was 
increased to modulate the surface coverage (Table 1).
Bioassay. The GMR sensors were functionalized with 99% (3-Aminopropyl)triethoxysilane (APTES, catalog 
#440140, Sigma Aldrich) for 1 hour at 37 °C, followed by Biotin (EZ-Link™ NHS-PEG12-Biotin, catalog #21312, 
ThermoFisher Scientific) incubated for 1 hour at 37 °C, and then coated with 2% BSA (Blocker™ BSA (10× ) in PBS, 
catalog #37525, ThermoFisher Scientific) for 30 min at room temperature. The reference sensors were covered with 
epoxy and part of sensors had only BSA without biotin as negative controls. The measurements were conducted with 
magnetometry to ensure the efficacy of MNPs binding via biotin-streptavidin interaction, followed by 1× PBS washing 
3 times to remove unbound MNPs, and then performed MRX to detect the MNPs’ relaxation signal via specific binding.
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